XML 21 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Jan. 31, 2017
Cash flows from operating activities:      
Net income $ 298,003 $ 108,263 $ 218,120
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 117,986 128,408 135,330
(Benefit) provision for deferred income taxes (11,414) 8,329 (4,801)
Share-based compensation expense 18,104 14,517 18,291
Impairment 3,544 11,410 4,341
Loss on disposition of property and equipment, net 3,492 4,037 3,667
Changes in assets and liabilities:      
Receivables (4,012) (21,744) 20,934
Inventory (21,696) (8,644) (9,963)
Prepaid expenses and other assets 8,605 12,967 (10,359)
Payables, accrued expenses and other liabilities 34,012 45,516 39,692
Net cash provided by operating activities 446,624 303,059 415,252
Cash flows from investing activities:      
Cash paid for property and equipment (114,924) (83,813) (143,714)
Cash paid for marketable securities (396,646) (281,385) (318,742)
Sales and maturities of marketable securities 267,072 243,818 243,159
Acquisition of business     (15,325)
Net cash used in investing activities (244,498) (121,380) (234,622)
Cash flows from financing activities:      
Repayments of long-term debt     (150,000)
Proceeds from the exercise of share-based awards 13,618   4,096
Share repurchases related to share repurchase program (121,397) (157,044) (45,787)
Share repurchases related to taxes for share-based awards (10,245) (2,182) (2,052)
Net cash used in financing activities (118,024) (159,226) (193,743)
Effect of exchange rate changes on cash and cash equivalents (8,062) 11,627 (4,023)
Increase (decrease) in cash and cash equivalents 76,040 34,080 (17,136)
Cash and cash equivalents at beginning of period 282,220 248,140 265,276
Cash and cash equivalents at end of period 358,260 282,220 248,140
Cash paid during the year for:      
Income taxes 102,211 83,986 111,958
Non-cash investing activities—Accrued capital expenditures $ 7,193 $ 10,144 $ 17,020